Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07436637 · ClinicalTrials.gov registry record · NA
Guardant Shield Colorectal Cancer Screening
A NA study, sponsored by University of Miami.
- Not yet
- Registry status
- NA
- Development phase
- 500
- Enrollment target
NCT07436637: Clinical Trial NA study, sponsored by University of Miami.
NCT07436637 is a NA study that has not yet begun recruiting, run by University of Miami. The registered enrollment target is 500 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07436637, a NA study, has not yet begun recruiting, sponsored by University of Miami.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
Study Summary
The purpose of this research is to identify individuals overdue for colon cancer screening and send them a reminder to complete their screening, which includes standard of care colonoscopy or stool-based testing. The investigators are randomizing patients (like a flip of a coin) to either receive the standard reminder by mail/email or to receive the standard reminder and have the option to provide a blood sample for screening (ShieldTM by Guardant).
Primary Outcome
Percentage of participants, between both arms, who complete colorectal cancer screening within 6 months.
Interventions
- PROCEDURE Blood Sample Collection
- BEHAVIORAL Screening Reminder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2026-06-30 |
| Est. Completion | 2027-04-01 |
| Phase | NA |
What is known before NCT07436637 opens enrollment
NCT07436637 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).
The record links to 0 conditions, and to 2 interventions - of which Blood Sample Collection is the first listed.
NCT07436637 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07436637 about?
NCT07436637 is a clinical study titled "Guardant Shield Colorectal Cancer Screening". The purpose of this research is to identify individuals overdue for colon cancer screening and send them a reminder to complete their screening, which includes standard of care colonoscopy or stool-based testing. The investigators are randomizing patients (like a flip of a coin) to either receive th...
What is the current status of trial NCT07436637?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2026-06-30. Estimated completion is 2027-04-01.
What interventions are being tested in trial NCT07436637?
The interventions under investigation include: Blood Sample Collection (PROCEDURE), Screening Reminder (BEHAVIORAL).
Who is sponsoring clinical trial NCT07436637?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07436637's enrollment target sits among peer trials
500 193rd of 2000 higher than 1,788 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI